Trial intelligence / Profile preview

Response Variability in STAR*D (Ancillary)

NCT00375843Phase 4Completed

Sponsor
National Institute of Mental Health
Start
Jan 2005
Primary completion
Jun 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of escitalopram in major depressive disorder (MDD), sponsored by National Institute of Mental Health. Started Jan 2005; status: completed.

02

Drugs

escitalopram
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT00375843.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00375843.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call